All attending UK organisations

UK companies attending Bio-Europe 2015 as part of the official delegation

(Click here to search profiles):

UK Pavilion exhibitors - booth 56*
BioPartner UK, Dora Wirth (Languages), The BioHub Birmingham

UK delegation - booth 56a/d*:
Absolute Antibody,Aptus Clinical,Atopix Therapeutics,BioClone Ltd,Biopharma Technology,Canbex Therapeutics,CatSci,Chiltern International,CIMYM BioSciences,Clinical Network Services (CNS),Crescendo Biologics,Curileum,Custom Pharmaceuticals,Datatrial Limited,Diabetology,ERA Consulting UK,Fahy Gurteen Laboratories,Francemed Pharma,Fusion Antibodies,Glythera,Horizon Discovery,IDACO Consulting,Illingworth Research,KWS Biotest,Manchester Science Partnership,MGB Biopharma,Midatech,Neem Biotech,Scottish Development International (SDI),Selcia,Spero Oncology,Synpromics,SYNthesis med chem,ULS (BIA, Bionow, BioPartner, MediWales, One Nucleus)

Regional groups - booth 56*:
North of England - Bionow, Aptus Clinical, Datatrial, Glythera, Illingworth Research, Manchester Science Partnership
Wales - Cardiff University, CatSci, MediWales, Midatech, Neem Biotech
Scotland - MGB Biopharma, Scottish Development International (SDI), Spero Oncology, Synpromics

UK Presenting companies:
Canbex Therapeutics, Crescendo Biologics, Elasmogen, Fahy Gurteen Laboratories, Lamellar Biomedical, Medherant, Oxford Biomedica, Re-Pharm, Ripptide Pharmaceuticals, Verona Pharma

All attending UK organisations:

3M Health Care, Abingworth, Absolute Antibody,  Abzena, ADC Therapeutics, Alacrita, Allergan, Almac Discovery, Amdipharm Mercury Company, Amgen, Apitope, Aptus Clinical, Astex Pharmaceuticals, Aston University - Pharmacy, Atelix, Atopix Therapeutics, Aurelia Bioscience, Barrington James, Bicycle Therapeutics, BioAscent Discovery, BioClone, BioPartner UK, Biopharma Technology, BioPharmaSpec, BioProcess International, Bird & Bird LLP, BRISTOWS LLP, Britannia Pharmaceuticals, BTG International, Canbex Therapeutics, Cancer Research Technology, Cardiff University, CatSci, Causeway Therapeutics , Celerion, Cello Health Consulting, Chiltern International, Chronos Therapeutics, CIMYM BioSciences, Circassia, Citeline, Clinical Accelerator, Clinical Network Services (CNS), Clinigen Healthcare, Cmed Clinical Services, Cobra Biologics, Coulter Partners, Covance, CPI, Creabilis, Crescendo Biologics, Curileum, Custom Pharmaceuticals, Datatrial, Decision Resources Group plc, Diabetology, Domainex, Dora Wirth, Duke Street, Durbin PLC, Edinburgh Molecular Imaging, Edison Investment Research, Egamid, Eisai, Elasmogen, Epidarex Capital, ERA Consulting UK, Ergomed PLC, Euromedica, European Medicines Agency, EUSA Pharma, EVA Pharma Consultants, Evaluate, Fahy Gurteen Laboratories, Ferghana Partners, FinVector Vision Therapies, FLYNN PHARMA, Fort Rock Capital, Francemed Pharma, F-star Biotechnology, Fujifilm Diosynth Biotechnologies, Fusion Antibodies, Galen, GHO Capital Partners LLP, Gilead Sciences Europe, Glide Technologies, GlobalData, Glythera, groupH, Guidepoint, Haemostatix, Haseltine Lake, HC Pharma Consultancy, Heptares Therapeutics, Horizon Discovery, Hypo-Stream, ICR, IDACO Consulting, IDBS, Illetrop, Illingworth Research, ImmuPharma plc, Imperial Innovations, IMS Health, Informa PLC, Innova Biosciences, Instinctif Partners, inVentiv Health, Isogenica, Ithaka Life Sciences, JGSbiopharma, Johnson & Johnson, Karustherapeutics, KKBio, Kreos Capital, Kronberg Associates, KWS Biotest, Kymab, Lamellar Biomedical, Life Sciences Hub Wales, Manchester Science Partnership, Martindale Pharma, Medherant, Medius Associates, Mergermarket Group, MGB Biopharma, Midatech, MISSION Therapeutics, Mitsubishi Tanabe Pharma Corporation, MVM Life Science Partners LLP, Nature Publishing Group, Neem Biotech, Norgine, Norgine Ventures, Novasecta, OBN UK, ONO PHARMA, Optimal Strategix Group, Osborne Clarke, Oxford BioMedica, Oxford Genetics, OxSonics, Paul Hastings (Europe) LLP, Perella Weinberg Partners UK LLP, Phacilitate, Phacilitate, Pharma Television, PharmaTelevision, PharmaVentures, PharmaWave, Piper Jaffray, PlaqueTec, Portsmouth University, PRA Health Sciences, Premier Research, Present value, ProImmune, ProStrakan, Proximagen, Psioxus Therapeutics, Queen Mary University of London - BioPharma, Randox Biosciences, Redx Pharma Plc, Re-Pharm, ReViral, Sage Healthcare, Samedan, Sareum, Scius Communications, Scottish Development International (SDI), Scrip Intelligence, Selcia, Shield Therapeutics, Shionogi, Shire Pharmaceuticals, Sidley Austin LLP, Silence Therapeutics, Sixth Element Capital LLP, SmartAnalyst, Spero Oncology, SUMMIT, Sygnature Discovery, Synpromics, SYNthesis med chem, Talentmark / RMA and Assoc., TC Biopharm, Teijin Pharma, Tepnel Pharma Services, The Binding Site Group, The Bio Hub Birmingham, The Fulford Group, The Research Network, The Royal Veterinary College, Therakind, Torreya Partners, TPDescamps Associates, transB ., UCB, ULS (BIA, Bionow, BioPartner, MediWales, One Nucleus), University of Aberdeen - Scottish Biologics Facility, University of Dundee - Drug Discovery Unit, University of Leicester - Enterprise & Business Development, University of Nottingham - Centre for Biomolecular Science, University of Strathclyde, Vectura, Vernalis plc, Verona Pharma plc, Virdisgroup, Visium Asset Management, William Blair International, Wragge Lawrence Graham, Xention 

last updated Oct 26th

*Join them here!